Global Controlled Release Drug Delivery Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Controlled Release Drug Delivery Market Research Report 2024
Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.
According to MRAResearch’s new survey, global Controlled Release Drug Delivery market is projected to reach US$ 74320 million in 2033, increasing from US$ 43280 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Controlled Release Drug Delivery market research.
Controlled drug delivery systems can include the maintenance of druglevels within a desired range, the need for fewer administrations, optimal use of the drug in question and increased patient compliance.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Controlled Release Drug Delivery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Depomed
Coating Place
Corium
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck
Aradigm
Segment by Type
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Controlled Release Drug Delivery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Controlled Release Drug Delivery market is projected to reach US$ 74320 million in 2033, increasing from US$ 43280 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Controlled Release Drug Delivery market research.
Controlled drug delivery systems can include the maintenance of druglevels within a desired range, the need for fewer administrations, optimal use of the drug in question and increased patient compliance.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Controlled Release Drug Delivery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Depomed
Coating Place
Corium
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck
Aradigm
Segment by Type
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Segment by Application
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Controlled Release Drug Delivery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source